Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Alchem International Launches Third Generation Phytomedicine to Combat Cough, Cold and Flu


News provided by

Alchem International Pvt Ltd

28 Apr, 2016, 12:18 IST

Share this article

Share toX

Share this article

Share toX

NEW DELHI, April 28, 2016 /PRNewswire/ --

- PhytoRelief-CC Sugar-free Lozenges Contains Concentrated Pharmaceutical Grade Molecular Extracts of Curcuma Longa (Turmeric Phyto Extract), Punica Granatum (Dantabija Phyto Extract) and Zingiber Officinale (Ginger Phyto Extract) 

- In International Clinical studies, PhytoRelief-CC's Patented Formulation has Proven to be Very Effective for Conditions like Cold and Flu Symptoms, Upper Respiratory Tract Infections and Mucosal Lesions of the Mouth and Throat 

AlchemLife, branded under Alchem International launched a phytomedicine for natural relief from cold, cough and flu called PhytoRelief-CC. 

PhytoRelief-CC comes in the form of sugar-free lozenges which contain concentrated and purified molecular extracts of curcuma longa (turmeric phyto extract), punica granatum (dantabija phyto extract) and zingiber officinale (ginger phyto extract). The synergistic effect of these nature-derived ingredients offers a host of benefits to quickly and naturally cure symptoms of sore throat, cough, cold and flu.

     (Logo: http://photos.prnewswire.com/prnh/20160428/10145057 )

PhytoRelief-CC has very potent anti-viral, anti-bacterial, immuno-modulatory, anti-inflammatory, anti-allergic, analgesic and anti-oxidant properties. These properties help to be an effective immunity builder. It has been developed using Alchem's proprietary Phytoplex™ technology based on cutting-edge science which isolates active plant molecules in a way that preserves the 'natural balance' and 'synergistic effects' present in the original plant material to deliver natural remedies with unsurpassed efficacy and without any side effects.

Raman Mehta, Founder, Alchem International, said, "PhytoRelief-CC provides quick and effective relief naturally, combining the power of traditional medicinal herbs with cutting-edge science and research. We expect a very encouraging response as there is presently no natural offering in the market that is backed by clinically proven results for the prevention and treatment of symptoms of common cold, sore throat, cough and flu."

Published clinical studies in renowned international journals like Minerva Gastroenterol Dietol and Minerva Medica, have proven PhytoRelief-CC to be very effective for conditions like cold and flu symptoms, upper respiratory tract infections, and mucosal lesions of the mouth and throat (associated with Bechet's disease).

Compared to the placebo, PhytoRelief-CC led to reduction of signs and symptoms of cold and flu within 3-5 days, 83% reduction in bacterial load in oral cavity within 3 days and exhibited effective anti-viral activity against various strains of influenza (A and B). Studies have also shown significant improvements in treating disorders of the mouth, throat and upper respiratory tract infections within just 4-5 days. In simple terms, the medicine provides natural effective relief from common cold, cough, sneezing, stuffy nose, itching throat and other flu symptoms.

PhytoRelief-CC will be distributed in phases across the country at all pharmacy outlets.

Sudhir Mehra, Senior Vice President, Alchem International, said, "The product will first be made available across north India and subsequently register its presence in other parts of India."

About Alchem International

Alchem International develops and markets third generation phytomedicines i.e. phytomedicines which undergo international clinical studies for efficacy and safety, under the brand name AlchemLife. Third generation phytomedicines are more efficacious than regular phytomedicines and have no side effects because of Alchem International's proprietary extraction called Phytoplex™ technology.

Third generation phytomedicines have been developed by applying modern science to traditional systems of medicine from across the world including Chinese, African, South American, European and Indian. Third generation Phytomedicines are ideally suited for long-term treatment of ailments as they have no side effects. They can be used for primary therapy, or as adjuncts to primary therapy, that deliver long-term results with no side effects.

Alchem International has over 75 years of experience in manufacturing phytochemical-based Active Pharmaceutical Ingredients (APIs). Its phytochemicals plant, the biggest in India, is certified by the US FDA, WHO-GMP and AFSSAPS (The French Agency for the Safety of Health Products) and vendor validated by companies across the world. 80% of its revenues are generated from global exports.

The top selling third generation phytomedicine brands under AlchemLife include Flexiqule (joint care), Liverubin (liver care) Miraqule C 100 (cardio care), ProstaQuil (prostate care) and PhytoRelief CC (flu care).

For further information, please visit: http://www.alchemlife.com/ orhttp://www.alchemlife.in

Facebook: https://www.facebook.com/AlchemLifeIndia/

Media Contact:
Shaelja Gulati
Marketing Specialist
Alchem Phytoceuticals
[email protected]
+91-9599779947

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.